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Under appropriate conditions, monoclonai antibodies (mAb), ~ either to the T 
cell antigen receptor or to its associated structures, T3, can mimic the effects of 
antigen  and  activate  human  T  cells  (1,  2).  Previous  studies  (3,  4)  from  this 
laboratory indicate that this activation depends on the ability of the T3-antigen 
receptor complex to increase free cytoplasmic calcium ions ([Car+]i). This conclu- 
sion is based on the following observations: In the presence of phorbol myristate 
acetate (PMA), mAb either to the antigen receptor heterodimer or to T3 activate 
the human  T  cell line, Jurkat,  to produce the lymphokine interleukin  2  (IL-2) 
(2-5). These same antibodies elicit prompt,  sustained increases in [Car+]i when 
added to Jurkat cells that are loaded with the Car+-sensitive fluor, quin 2 (3, 4). 
Comparable  increases  in  [Car+]i,  induced  by the  Ca  r+  ionophore,  ionomycin, 
activate Jurkat in the presence of PMA, and also activate mutants of  Jurkat which 
fail to express the T3-antigen  receptor complex (4).  Stimulation of Jurkat with 
either ionomycin or antibodies to the T3-antigen receptor complex lead to the 
appearance of the same new phosphoproteins, suggesting that the ionophore and 
the  antibodies  activate  the  same  protein  kinases  (4).  These  findings  are  not 
restricted  to Jurkat.  Using  antibodies against  T3,  similar  results  indicate  that 
increases in [Car+]i play a crucial role in receptor-mediated activation of a second 
malignant  T  cell line,  Hut 78, as well as of bulk cultures of human peripheral 
blood T  cells (our unpublished observations). 
In order to investigate further the process of transmembrane  signalling by the 
T3-antigen receptor complex, we studied the mechanism by which this complex 
increases  [Ca2+]i. Herein,  we  demonstrate  that  the  initial  receptor-mediated 
increase in  [Car+]i  is due to the release of Ca  ~+ from intracellular  stores.  This 
release of Ca  2+, in turn,  appears to be mediated by receptor-induced increases 
in inositol trisphosphate  (IP3),  the putative mobilizer of intracellular  Ca  r+ for a 
variety of hormone receptors (6-10). The process of transmembrane  signalling 
by  the  T3-antigen  receptor  complex,  therefore,  is  intimately  linked  to  the 
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activation of a  phosphodiesterase  that  is capable of hydrolyzing polyphosphoi- 
nositides to inositol phosphates (6). These findings tie the T  cell antigen receptor 
to a  potent membrane transducing mechanism, because the hydrolysis of poly- 
phosphoinositides  generates  a  number  of potential  intracellular  messengers, 
including diacylglycerol and arachidonate, as well as IPn (reviewed in 6 and  11). 
Materials and Methods 
Cells and mAb.  Jurkat E6-1 was passaged as described (3). C305, an IgM-kappa mAb, 
recognizes the antigen-receptor heterodimer on Jurkat  (5).  C373,  another IgM-kappa 
mAb, reacts with the E rosette receptor on human T  cells (57. OKT3 was obtained from 
Ortho Pharmaceutical (Raritan, N  J). 
Reagents.  Ionomycin was a gift from Squibb Corp. (Princeton, N  J). Purified IPs and 
inositol bisphosphate (IP~), which were prepared by the method of Grado and Ballou (12) 
from  phosphatidylinositol-4,5-bisphosphate and  phosphatidylinositol-4-monophosphate, 
respectively, were a  kind gift of Dr, Steven Watson (12).  All chemicals were obtained 
from Sigma Chemical Co. (St. Louis, MO). 
Determination of Free Cytoplasmic Calcium.  Jurkat cells were loaded with 5 ~M of the 
acetoxymethyl ester of quin 2 (Amersham Corp., Arlington Heights, IL) and the fluores- 
cence of the cellular suspension (107 cells/ml) was monitored with a Perkin-Elmer 650-40 
spectrofluorimeter as described (3). [Ca~+]i was calculated by the method of Tsien et al. 
(13). Measurements were made in a solution (pH 7.40) containing 125 mM NaC1, 5 mM 
KCI,  1 mM Na~HPO4,  1 g/liter glucose, 25 mM Hepes, 0.1% bovine serum albumin,  1 
mM CaC]2, and 0.5 mM MgCI~ ("saline"). The cellular quin 2 content in these experiments 
was  60-80 pmol of quin  2  per  106 cells.  With extracellular Ca  2÷ depleted, substantial 
blunting of the C305-induced increase in [Ca~+]i was observed with higher quin 2 contents 
(e.g. 0.3-0.4 nmol quin 2 per 106 cells), presumably due to the predicted ability of quin 
2  to buffer transient increases in  [Ca~+]i (data not  shown) (13).  In  the  Ca2+-depletion 
experiments, EGTA (final concentration, 10 mM) was added to the cellular suspension 
from a 200 mM stock (pH 7.40) 1-10 rain before the addition ofC305. The extracellular 
Ca  2+ concentration in these experiments was estimated by adding EGTA (to 10 mM) in 
the same "saline" solution containing 2 #M quin 2 (free acid form; Calbiochem-Behring, 
San Diego, CA) in the absence of cells. 
Measurement of [SH]Inositol Phosphates.  [SH]Inositol phosphates were separated and 
quantified by the methods described previously (9,  14,  15). Incorporation of [SH]inositol 
into phospholipid was achieved by incubating Jurkat cells (107 cells/ml) with 40 ~Ci/mi of 
[SH]inositol  (37  MBq/ml;  Amersham  Corp.)  for  3  h  at  37°C,  followed by extensive 
washing, resuspension at 107 cells/ml in "saline", and incubation for an additional 60 min 
at 37 ° C. Aliquots (1 ml) of this cellular suspension were then added to 5-ml culture tubes, 
and the appropriate additions were made. Antibodies were added to a final dilution of 
1:400, and ionomycin was added to 1 t~M (from stock 200/~M in dimethyl sulfoxide). For 
30-s time points, ceils  were stimulated  in microfuge tubes and directly processed.  For 
other time points, incubations were continued at 37°C, then the cells were transferred to 
microfuge tubes and sedimented in an Eppendorf 5414 centrifuge. After aspiration of 
the media, 0.750 ml of chloroform-methanol (1:2) was added to the cellular pellet. The 
phases were separated by the addition of 0.250 ml H~O and 0.250 ml chloroform, and 
the upper phase transferred to a borosilicate tube containing 2.3 ml H,O. This diluted 
aqueous phase was  then applied to columns made from  1.2  ml of a  0.5 g/ml aqueous 
slurry of Dowex l-X8 100-200 mesh (Sigma Chemical Co.) in formate form. [3H]Inositol 
and [3H]glycerophosphorylinositol  were eluted with 12 ml of 60 mM sodium formate plus 
5  mM  disodium  tetraborate,  and  were  not  routinely counted.  The column was  then 
washed  with  an  additional  8  ml  of the  same  buffer.  During  this  wash,  the  eluted 
radioactivity fell to background levels.  Inositol phosphate (IPi), IP~, and IPs were then 
sequentially eluted with 4 ml of 0.2 M ammonium formate plus 0.1 M formic acid, 18 ml 
of 0.4 M ammonium formate plus 0.1  M formic acid, and 16 ml 1 M ammonium formate 
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washed with five to eight column volumes of the same buffer prior to the elution of the 
next  peak;  during  these  washes,  eluted  radioactivity  returned  to  background  levels. 
Radioactivity was determined by scintillation counting in Aquasol (New England Nuclear, 
Boston, MA). This method unequivocally separates IP~, IP2, and IP3 from one another, 
but does not allow one to distinguish among the various possible isomers of each of these 
inositoi phosphates (14). 
Permeabilized Cell Experiments.  The ability of purified IP3 to release Ca  2÷ from intra- 
cellular stores in Jurkat was tested by a method adapted from that used by Joseph et al. 
(8) with hepatocytes. Jurkat cells (2 x  107 celis/ml) were permeabilized with saponin (60 
#g/ml) in  thermostatically maintained (37°C)  quartz  cuvettes in  a  medium (pH  7.20) 
containing  110 mM KCI, 10 mM NaCi,  1 mM KH~PO4, 5 mM KHCOa, 20 mM Hepes, 
20  mM  creatine phosphate,  10  U/ml  creatine kinase,  and  0.3  mM  MgCi2.  The Ca  2÷ 
concentration  in  the cuvette was monitored with  20  ttM  quin  2  (free acid  form) in  a 
Perkin-Elmer  spectrofluorimeter  (excitation  at  339  nm,  emission  at  492  nm).  After 
permeabilization was complete, Mg~÷-ATP was added to a final concentration of 3 raM. 
IPs was added from a 100 #M stock. At the end of each experiment, maximal fluorescence 
was determined by the  addition  of 1 mM  Ca  2+, and the  minimal fluorescence by the 
subsequent addition of 10 mM  EGTA and sufficient  1 M Tris Base to raise the pH to 
>8.3. The Ca  2+ concentration was then calculated by the method of Tsien et al. (13).  It 
should be noted that, as the cells are permeabilized, this technique measures the Ca  ~÷ 
concentration  in  the  entire  suspension.  Changes in this Ca  2÷ concentration,  therefore, 
cannot be compared directly to the measurements of [Ca2÷]i using intracellularly trapped 
quin 2. 
Results 
Antibodies to the T3-antigen  receptor complex cause substantial increases in 
[Ca2+]i when added to Jurkat cells that are loaded with the Ca  2÷ indicator quin 2 
(Fig. 1 B) (3, 4). Such receptor-mediated increases in [Ca2+]i can be due to uptake 
of extracellular Ca  ~+, release of Ca  ~÷ from intracellular stores, or a combination 
of these processes. To distinguish among these possibilities, we tested the ability 
of C305, an  IgM mAb against the antigen  receptor heterodimer on Jurkat,  to 
increase [Ca2+]i when extracellular Ca  2+ is depleted. Basal [Ca2+]i in Jurkat is ~80 
nM  (3,  4).  When extracellular  Ca  2+ is reduced to <60 nM by 10 mM EGTA, 
C305  still  elicits  a  substantial  increase  in  [Ca~+]i (Fig.  1A).  Furthermore,  the 
initial rate of the increase in the fluorescence of quin 2 is identical to that seen 
in  the  presence  of  1  mM  extracellular  Ca  2+.  This  initial  receptor-mediated 
increase in [Ca2+]i, occurring in the absence of a Ca  2+ gradient across the plasma 
membrane, must be due to the release of Ca  2+ from intracellular stores. 
The  T  cell antigen  receptor,  therefore,  generates some signal  that,  in turn, 
releases  Ca  2+  from  intraceUular  sites.  As  IP3  has  been  implicated  as  such  a 
messenger for a number of hormone receptors, we measured inositol phosphates 
in Jurkat  by loading  these  cells with  [SH]inositoi and  separating  the  different 
[~H]inositol phosphates by anion-exchange  chromatography  (6-10,  14,  15). As 
shown  in  Fig.  2,  the  addition  of C305  to Jurkat  results  in  a  nearly  twofold 
increase in IPs, as well as a 40% increase in IP2, within 30 s (it is not technically 
possible to measure earlier time periods). The levels of IPs and IP~ continue to 
rise  during  the  first  10  min  after  the  addition  of C305  (Fig.  3) and  are  still 
elevated at  30 min  (data not shown).  Increased  levels of IP1  are not detected 
until at least 60 s after the addition of antibody (Fig. 2), but rise thereafter (Figs. 
2 and 3). 
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FIGURE  1.  C305,  an antibody against the antigen receptor heterodimer,  increases [Ca2+]i 
when extracellular Ca  2+ has been depleted. Jurkat cells were loaded with the acetoxymethyl 
ester of quin  2,  and  the  fluorescence of the  cellular suspension monitored over  time,  as 
described in Materials and Methods. [Ca*+]i, calculated by the method of Tsien et al. (13), is 
displayed on the vertical axis. A,  EGTA was added to a  final concentration of 10 mM one 
minute prior to the addition of C305.  This immediately reduced extracellular Ca  *+ to <60 
nM. Under these conditions [Ca*+]i in unstimulated cells fell, over a period of 5 min, to ~40 
nM (data not shown). Comparable increases in quin 2 fluorescence were seen after a  I0 min 
incubation in  10 mM EGTA (data not shown). This tracing is representative of six separate 
experiments. B, C305 was added in the presence of 1 mM extracellular Ca  P+. 
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FIGURE 2.  Perturbation of the antigen receptor heterodimer on Jurkat increases [SH]inositol 
phosphates. The levels of [SH]IPs (O), [3H]IP~ (1), and [3H]IPi (A) after the addition of C305 
are expressed as a percentage of the values in unstimulated cells at time 0. After Jurkat cells 
7  $  $  (4 x  10  cells in 4 ml) were loaded with [ H]inositol, the [ H]inositol phosphates were extracted 
from  10  ~ unstimulated cells, and C305 was added to the remaindel:. One milliliter aliquots 
were removed subsequently for each time point. The indicated time points are the interval 
from the addition of antibody to the lysis of the cells in chloroform-methanol. The inositoi 
phosphates were separated by anion-exchange chromatography as outlined in Materials and 
Methods. Levels of [3H]inositol phosphates in the unstimulated cells were: IPa, 249 cpm; IP~, 
799 cpm; and IP~, 466 cpm. These data are representative of three separate experiments. 450  TRANSMEMBRANE  SIGNALLING BY  THE  T  CELL  RECEPTOR 
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FIGURE 3.  Antibodies a~ainst the T3-antigen receptor complex on Jurkat cells generate 
r  r~,  I  s  inc eased  levels  of:  (A)  [ H]inositol tr'sphosphate,  (B)  [ H]inositol bisphosphate, and  (C) 
[SH]inositol phosphate. Jurkat cells were loaded with [aH]inositol as described in Materials and 
Methods, and then divided into aliquots, which received either C305 (0), OKT3 (m), C373 
(O), or 1 #M ionomycin (I-'1),  or which were left unstimulated (A). Results are expressed as the 
change in cpm from unstimulated cells at time 0, and are expressed as the mean +  SEM for 
three separate experiments. Mean values for unstimulated values at time 0 were: IPs,  193 + 
70 cpm; IP2, 1,456 _+ 598 cpm; and IP~, 547 + 82 cpm. Values that are significantly  elevated 
over unstimulated cells, C373-treated cells, and ionomycin-treated cells are designated by * 
and 4: for p values <0.05 and <0.02, respectively (Student's paired t test). No values for C373- 
treated, or ionomycin-treated cells significantly  differed from those of unstimulated cells. The 
mean value for unstimulated cells incubated throughout the course of the experiment is shown 
at the 10 min time point, and superimposes on the C373 mean values. [SH]Inositol phosphates 
were separated and quantified as described in Materials and Methods. 
in  IPs.  To  insure that this increase in IPs is not a  consequence  of the receptor- 
mediated increase in [Ca2+]i, we studied the levels of inositol phosphates in Jurkat 
cells that are stimulated with  1 ;zM ionomycin. This concentration of ionophore 
does not change  the  levels of IPs,  IP~, or  IP1  (Fig.  3),  even though  it increases 
[Ca~+]i to  levels comparable  to  those  seen after the  addition of C305  (4).  The 
specificity of the  C305-induced  increases in  inositol phosphates  was  confirmed 
by studying two additional mAb.  OKT3,  an  IgG mAb,  recognizes a  T3  deter- 
minant and increases [Ca2+]i (3). As expected, this antibody generates significant 
increases  in  all  three  inositol  phosphates  (Fig.  3).  In  contrast,  C373,  an  IgM 
mAb against the T  cell E  rosette receptor, binds to Jurkat,  but does not change IMBODEN  AND  STOBO  451 
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FICUnE  4.  Purified inositol trisphosphate releases Ca  n+ from saponin-permeabilized Jurkat 
cells. Jurkat cells (2 x  107 cells/ml) were permeabilized with saponin as described in Materials 
and Methods. The free Ca  2+ concentration in the suspension, ([Ca~+]), was monitored with 
quin 2 (free acid form). ATP was added to a final concentration of 3 mM. After the addition 
of ATP, [Ca  ~+] fell to 90 nM (which approximates the level of [Ca2+]i in intact, unstimulated 
Jurkat cells).  IP3 was added  from a  100  #M  stock  to a  final concentration of  1 #M.  This 
preparation of IP3 did not contain detectable contaminating amounts of Ca  2+, as evidenced by 
the failure of IPs to_change quin 2 fluorescence in the absence of cells (data not shown). These 
data are representative of 10 separate experiments. 
[Ca2+]i (4, 5). The addition of C373 to Jurkat does not affect the levels of any of 
the inositol phosphates (Fig. 3). 
Increases in IPs and in [Ca2+]i are both early events in the antigen receptor- 
induced activation of  Jurkat. The ability of IP3 to mobilize intracellular Ca  2÷ in 
other cells, however, suggests that these events are not independent and that the 
increase in IPs might be responsible for the increase in [Ca2+]i. Accordingly, we 
tested  the ability of purified  IPs  to  release  Ca  2+  from  intraceUular stores  in 
Jurkat.  In these experiments Jurkat cells are permeabilized with saponin,  and 
the concentration of Ca  2+  in  the  suspension  is  measured with  quin  2.  After 
permeabilization, the addition of ATP leads to uptake of Ca  2+, as evidenced by 
the fall in quin 2 fluorescence (Fig. 4). The subsequent addition of IP3 results in 
a  prompt increase in fluorescence, demonstrating that IPs releases Ca  2+ from 
permeabilized Jurkat cells. Release of Ca  ~÷ is detected with concentrations 9f IP3 
as low as 0.1  #M, and is maximal at  1 #M. This ability of IPs to release Ca  z+ is 
enhanced considerably by the prior addition of ATP, suggesting that IP3 mobi- 
lizes  Ca  2+  from an  ATP-dependent pool  of Ca  2+.  In  contrast,  there  was  no 
detectable change in the Ca  ~+ concentration in any of the three experiments in 
which purified  1  #M  IP2  was  added  to  permeabilized Jurkat  cells  (data  not 
shown). 
Discussion 
The studies presented here suggest that the process of transmembrane sig- 
nalling, by which the T3-antigen receptor complex activatesJurkat, involves the 
generation of IP3. Elevated concentrations of IPs release Ca  ~+ from intracellular 
stores and thereby increase [Ca2+]i. Previous studies have demonstrated that this 
increase in [Ca2+]i provides an essential signal for the receptor-induced appear- 
ance of IL-2 transcripts and the subsequent production of IL-2 biological activity 
by Jurkat cells (2-4). 
Several lines of evidence support  these conclusions. Antibodies to the T3- 
antigen receptor complex on the T  cell line, Jurkat, increase [Ca2+]i (Fig.  1) (3, 
4). These same antibodies generate significant elevations in the levels of IPs, ]P2, 452  TRANSMEMBRANE  SIGNALLING  BY  THE  T  CELL  RECEPTOR 
and IPl  (Figs.  2 and 3).  These increases in inositol phosphates appear to be a 
specific effect of perturbation of the receptor complex and are not merely the 
result of an  interaction  of mAb with  the cellular surface (Fig.  3).  A  crucial 
question, then, is whether the link between the receptor-mediated generation of 
inositol phosphates  and the receptor-mediated increase in  [Ca2+]i is  merely a 
temporal association, or whether one effect is a consequence of the other. The 
elevated levels of inositol phosphates are not secondary to the receptor-induced 
changes in [Ca2+]i. The Ca  ~+ ionophore, ionomycin, in a concentration of 1 #M, 
increases [Ca2+]i to levels that are comparable to those induced by antibodies to 
the T3-antigen  receptor complex, and can substitute  for these antibodies  in 
activating Jurkat (4).  This same concentration of ionophore does not affect the 
levels of any of the inositol phosphates (Fig. 3). The data in Figure 4 demonstrate 
that  one  of these  inositol  phosphates,  IPs,  could  function as  a  mobilizer  of 
intracellular stores of Ca  2+ in Jurkat. Purified IPs, in concentrations between 0.1 
and 1 #M, is able to release Ca  2+ from permeabilized Jurkat cells, indicating that 
this compound might mobilize intracellular Ca  ~+ after perturbation of the T3- 
antigen receptor complex. That the T3-antigen receptor complex does indeed 
mobilize Ca  2+ from intracellular stores is demonstrated by the ability of anti- 
antigen receptor antibody to increase [Ca2+]i when extracellular Ca  2+ is depleted 
(Fig.  1). 
Further support for the role of IP3 in mediating this increase in [Ca2+]i derives 
from similar findings in  other receptor systems. It  is  clear that  a  number of 
hormone receptors which mobilize intracellular Ca  2+ also generate substantial 
elevations in  inositol phosphates (reviewed in 6).  For example, the hepatocyte 
receptors for vasopressin and a~-adrenergic stimuli have been shown to stimulate 
hydrolysis of polyphosphoinositides, generate IP3,  and release Ca  ~+ from intra- 
cellular stores  (8-10,  16,  17).  Furthermore, purified  IP3  releases  Ca  2+  from 
perm,abilized hepatocytes (8,  10).  The concentrations of IPs that release Ca  ~+ 
from permeabilized hepatocytes are in the same range (0.1-1 #M) as the concen- 
trations that are required to mobilize Ca  2+ from permeabilized Jurkat cells (8, 
10).  These concentrations are substantially less than the intracellular levels of 
IPs  (10-50  #M)  that  are  estimated  to  occur in  stimulated  hepatocytes (10). 
Recent studies (7, 8,  10,  18) demonstrate that IPs mobilizes Ca  2+ from an ATP- 
dependent,  nonmitochondrial  pool  that  is  probably  within  the  endoplasmic 
reticulum. 
The receptor-mediated generation of IP3  is almost certainly due to the hy- 
drolysis of the phospholipid,  phosphatidylinositol bisphosphate  (PIPs),  as  this 
reaction is the only identified source of IP3 in mammalian cells (Fig. 5) (6). The 
increased levels of IP~ could be due either to dephosphorylation of IPs or to 
receptor-mediated hydrolysis of phosphatidylinositol phosphate (PIP). The lag 
in the appearance of IP~ indicates that hydrolysis of phosphatidylinositol (PI) is 
not an early, receptor-mediated event, and suggests that accumulation of IP~ is 
due to  the  breakdown of IP3  and  IP~.  The  initial  events in  transmembrane 
signalling by the T3-antigen receptor complex, therefore, appear to follow the 
course that  is  shown  schematically in  Fig.  5.  Appropriate  stimulation  of the 
receptor complex activates a  phosphodiesterase that generates IP3  from PIP2. IMBODEN AND  STOBO 
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FIGURE 5.  Model  of the early events in antigen receptor-mediated activation. Appropriate 
stimulation of the T3-antigen receptor complex activates a phosphodiesterase that hydrolyzes 
the phospholipid, PIP2. This reaction generates IPs and DG. IPs, a water-soluble compound, 
is released into the cytoplasm, where it mobilizes Ca  ~+ from intracellular stores and thereby 
increases [Ca~+]i. IPs  is  subsequently broken  down  to IP2 and  then  IP],  leading to  the 
accumulation of all three inositol phosphates after perturbation  of the receptor complex. 
Receptor-mediated hydrolysis of PIP may be an additional source of IP~. The lag in the 
appearance of IPi argues against direct breakdown of PI to IPi. lnositol can be recycled into 
PI, and then converted to polyphosphoinositides  by the action of specific  kinases (6). Although 
shown as a single unit in this scheme, the nature of the physical association between T3 and 
the antigen receptor heterodimer during activation is not known. Also, at least one chain of 
the antigen receptor heterodimer, as well as all three T3 proteins, appear to span the plasma 
membrane (24, 25). 
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IPs, a  water-soluble compound,  is released into the cytosol and  mobilizes Ca  ~+ 
from intracellular stores, leading to an increase in [Ca2+]i. 
While release of intracellular Ca 2+ accounts for the early effects of the antigen 
receptor on  [Ca~+]i,  the  sustained  increase  in [Ca2+]i requires  the  presence of 
extracellular  Ca ~÷  (Fig.  1).  There  are  several  possible  explanations  for  this 
observation. The prolonged elevation in [Ca2+]i could be maintained by slowing 
the mechanism of Ca ~+ extrusion without a change in the membrane permeability 
to  Ca ~+  (under  physiological  conditions,  the  gradient  of Ca  2+  across  plasma 
membranes is  104, and  is maintained by active extrusion of Ca  2+) (19).  Such a 
mechanism  appears  to  maintain  the  elevations  in  [Ca2+]i  in  hepatocytes after 
stimulation with either vasopressin or al-adrenergic stimuli (19).  Alternatively, 
the sustained  increase in  [Ca~+]i could be due to increased permeability of the 
plasma membrane to Ca  2+. In Jurkat,  however, there does not appear to be any 
uptake of extracellular Ca ~+ through a classical voltage-dependent Ca  2+ channel 
after perturbation of the T3-antigen receptor complex. The antigen receptor- 
mediated  changes  in  [Ca~+]i  are  not  affected  by  the  Ca ~÷  channel  blockers, 
nifedipine and verapamil, and can occur when extracellular Na ÷ is replaced with 
nonexchangeable choline (i.e. under conditions in which the cell cannot depolar- 
ize with a  Na ÷ influx; our unpublished observations). Furthermore, depolariza- 
tion  of Jurkat  by the addition  of K ÷ does not  change  [Ca2+]i,  suggesting  that 
Jurkat does not bear voltage-dependent Ca ~+ channels (our unpublished  obser- 
vations).  The possibility that  IPs can  translocate  Ca 2+ across the plasma  mem- 
brane, to our knowledge, has not been tested directly. It is not clear whether the 
sustained  increase in  [Ca2+]i  is  important  for activation,  or whether the  initial 
peak increase in [Ca~+]i suffices. This issue cannot be approached by depleting 
extracellular Ca 2÷,  as  such  treatment  adversely affects cellular viability within 
several hours (our unpublished observation). 
Perturbation of the T3-antigen receptor complex by C305 generates higher 
levels of inositol phosphates  than  does perturbation of the complex by OKT3 454  TRANSMEMBRANE  SIGNALLING  BY  THE  T  CELL  RECEPTOR 
(Fig.  3).  It is not known whether this difference is a  function of the different 
specificities of these two antibodies, or whether this reflects perturbation of the 
complex by an IgM, as opposed to an IgG, antibody. The difference in the levels 
of inositol phosphates does not appear to be functionally important, as the two 
antibodies induce comparable changes in  [Ca2÷]i, and comparable amounts of 
IL-2 biological activity (3, 4).  This result is to be expected if stimulated Jurkat 
cells attain concentrations of IPs that are similar to those in receptor-activated 
hepatocytes, for these levels are one to two orders of magnitude greater than 
the concentrations apparently required to release Ca  2+ (10). 
We previously demonstrated that two signals are required to activate Jurkat 
to produce IL-2 (2).  Perturbation of the T3-antigen receptor complex by mAb 
transmits one signal by increasing [Ca2+]i (3, 4). The second signal can be provided 
by PMA (2-4).  PMA is a  potent activator of protein kinase C, an enzyme that 
plays a prominent role in signal transduction by a number of receptors and that 
appears  to  act  synergistically with  increases in  [Ca2+]i (20-23).  The  putative 
physiological activator of kinase C is diacylglycerol (DG), a necessary product in 
the generation of inositol phosphates from phosphoinositides (Fig. 5) (6, 11, 23). 
In Jurkat, perturbation of the receptor complex by mAb increases [Ca~+]i, but 
apparently is not capable of sufficiently activating kinase C as well. Hence, PMA 
is  required.  It  is  possible,  however, that,  under other conditions,  the  T  cell 
antigen receptor complex does generate all the signals required for activation. 
For example, the signalling capabilities  of the receptor might be affected by 
better crosslinking, or by other maneuvers that more closely mimic interaction 
with  antigen-presenting cells.  Of considerable interest in  this  regard are  the 
observations of Meuer et al (1). They are unable to activate alloreactive human 
T  cell  clones  to  produce  IL-2  with  either  anti-T3  antibodies  or  clonotypic 
antibodies alone, but can activate them by using these same antibodies attached 
to sepharose beads.  Under these conditions, then, the T  cell antigen receptor 
complex does generate the signals necessary for activation. Previous studies (3, 
4) indicate that one of these signals is an increase in [Ca~÷]i. The data presented 
here help to clarify the mechanisms involved in mediating this increase in [Ca  2+] 
i, and also provide an approach to a more complete understanding of the process 
of transmembrane signal transduction by the T3-antigen receptor complex. 
Summary 
Antibodies against the T3-antigen receptor complex can activate the human 
T  cell line, Jurkat, to produce interleukin 2 (2-5). This activation is initiated by 
a  receptor-mediated increase in the concentration of free cytoplasmic calcium 
ions [Ca~+]i (3, 4). In this communication, we investigate the mechanism by which 
the  receptor  complex  increases  [Ca2+]i in Jurkat  cells.  The  initial  receptor- 
mediated change in  [Ca2+]i can occur when extracellular Ca  2+ is  depleted by 
EGTA. Perturbation of the T  cell antigen receptor, therefore, generates a signal 
which mobilizes Ca  ~+ from intracellular stores. As inositol trisphosphate appears 
to function as such a  signal  for certain hormone receptors, we measured the 
levels of inositoi trisphosphate and of the other inositol phosphate compounds 
in Jurkat.  Antibodies to either the antigen receptor heterodimer or T3  deter- 
minants  result  in  marked  elevations  of all  three  inositol  phosphates.  These IMBODEN AND  STOBO  455 
changes  in  inositol  phosphates  are  not  secondary  to  the  receptor-mediated 
increases  in  [Ca2+]i  as  demonstrated  by  the  inability  of the  Ca 2÷  ionophore, 
ionomycin, to  affect the  levels of any of these  compounds.  In  concentrations 
between  0.1  and  1 #M,  purified inositol trisphosphate releases Ca  2÷ from per- 
meabilized Jurkat cells. Taken together, these data indicate that, during activa- 
tion, perturbation  of the T3-antigen  receptor complex generates inositol tris- 
phosphate.  This compound  functions as an  intracellular signal  to release Ca  ~÷ 
from intraceilular stores, leading to increases in [Ca~+]i. 
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